Abstract
Although mitral regurgitation (MR) is prevalent in patients with end-stage heart failure, the impact of mitral valve (MV) surgery on outcomes after left ventricular assist device (LVAD) implantation and morphologic changes of MV remains unclear. We retrospectively reviewed 74 patients who underwent LVAD implantation as a bridge to transplant. Of these, 11 (15%) underwent MV repair concomitant with or prior to LVAD implantation, while 27 patients with preoperative significant (moderate or greater) MR did not undergo concomitant MV surgery. The mean interval between LVAD implantation and the last echocardiographic examination was 913 days. Irrespective of MV surgery, significant LV reverse remodeling including decreased LV and left atrial dimension and improved MR severity was observed in all patients except for patients with prior MV surgery. Histopathological examination of explanted hearts removed at heart transplantation (n = 69) or autopsy (n = 5) revealed that the MV annulus was still dilated (mean perimeter 11.7 cm) in the patients with preoperative significant MR and no concomitant MV surgery. Concomitant MV surgery at the time of LVAD implantation for significant MR might not be always necessary for bridge to transplant or destination therapy cases. However, it might be required in patients having potential for cardiac recovery or patients with severe pulmonary hypertension and depressed right ventricle.
Similar content being viewed by others
References
MillerLW, PaganiFD, RusselSD, JohnR, BoyleAJ, AaronsonKD, ConteJV, NakaY, ManciniD, DelgadoRM, MacGillivrayTE, FarrarDJ, FrazierOH. HeartMate II clinical investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–96.
SlaughterMS, RogersJG, MilanoCA, RussellSD, ConteJV, FeldmanD, SunB, TatoolesAJ, DelgadoRM3rd, LongJW, WozniakTC, GhummanW, FarrarDJ, FrazierOH, HeartMate. II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.
PaganiFD, MillerLW, RusselSD, AaronsonKD, JohnR, BoyleAJ, ConteJV, BogaevRC, MacGillivrayTE, NakaY, ManciniD, MasseyHT, ChenL, KlodellCT, ArandaJM, MoazamiN, EwaldGA, FarrarDJ, FrazierOH. HeartMate II Investigators. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312–21.
KirklinJK, NaftelDC, PaganiFD, KormosRL, StevensonLW, BlumeED, MyersSL, MillerMA, BaldwinJT, YoungJB. Seventh INTERMACS annual report: 15000 patients and counting. J Heart Lung Transplant. 2015;34:1495–504.
HataH, FujitaT, ShimaharaY, SatoS, YanaseM, SeguchiO, SatoT, NakataniT, KobayashiJ. Early and mid-term outcomes of left ventricular assist device implantation and future prospects. Gen Thorac Cardiovasc Surg. 2015;63:557–64.
JohnR, NakaY, ParkSJ, Sai-SudhakarC, SalernoC, SundareswaranKS, FarrarDJ, MilanoCA. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. J Thorac Cardiovasc Surg. 2014;147:581–9.
WangTS, HernandezAF, FelkerGM, MilanoCA, RogersJG, PatelCB. Valvular heart disease in patients supported with left ventricular assist devices. Circ Heart Fail. 2014;7:215–22.
TodaK, FujitaT, DomaeK, ShimaharaY, KobayashiJ, NakataniT. Late aortic insufficiency related to poor prognosis during left ventricular assist device support. Ann Thorac Surg. 2011;92:929–34.
McKellarSH, DeoS, DalyRC, DurhamLA3rd, JoyceLD, StulakJM, ParkSJ. Durability of central aortic valve closure in patients with continuous flow left ventricular assist devices. J Thorac Cardiovasc Surg. 2014;147:344–8.
FujitaT, KobayashiJ, HataH, SeguchiO, MurataY, YanaseM, NakataniT. Right heart failure and benefits of adjuvant tricuspid valve repair in patients undergoing left ventricular assist device implantation. Eur J Cardiothorac Surg. 2014;46:802–7.
MilanoC, PaganiFD, SlaughterMS, PhamDT, HathawayDR, JacoskiMV, NajarianKB, AaronsonKD, Advance Investigators. Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures. Circulation. 2014;130(suppl 1):S3–11.
DunlaySM, DeoSV, ParkSJ. Impact of tricuspid valve surgery at the time of left ventricular assist device insertion on postoperative outcomes. ASAIO J. 2015;61:15–20.
TodaK, FujitaT, KobayashiJ, ShimaharaY, KitamuraS, SeguchiO, MurataY, YanaseM, NakataniT. Impact of preoperative percutaneous cardiopulmonary support on outcome following left ventricular assist device implantation. Circ J. 2012;76:88–95.
HataH, FujitaT, Ishibashi-UedaH, NakataniT, KobayashiJ. Pathological analysis of the aortic valve after long-term left ventricular assist device support. Eur J Cardiothorac Surg. 2014;46:193–7.
SlaughterMS, PaganiFD, RogersJG, MillerLW, SunB, RussellSD, StarlingRC, ChenL, BoyleAJ, ChillcottS, AdamsonRM, BloodMS, CamachoMT, IdrissiKA, PettyM, SobieskiM, WrightS, MyersTJ, FarrarDJ. HeartMate II Clinical Investigators. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29:S1–39.
MorganJA, TsiourisA, NemehHW, HodariA, KaramJ, BrewerRJ, PaoneG. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices. J Heart Lung Transplant. 2013;32:1255–61.
PatelJB, BorgesonDD, BarnesME, RihalCS, DalyRC, RedfieldMM. Mitral regurgitation in patients with advanced systolic heart failure. J Card. 2004;10:285–91.
StulakJM, TchantchaleishviliV, HaglundNA, DavisME, SchirgerJA, CowgerJA, ShahP, AaronsonKD, PaganiFD, MaltaisS. Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation. J Heart Lung Transplant. 2015;34:718–23.
TopilskyY, OhJK, AtchisonFW, ShahDK, BicharaVM, SchirgerJA, KushwahaSS, PereiraNL, ParkSJ. Echocardiographic findings in stable outpatients with properly functioning HeartMate II left ventricular assist devices. J Am Soc Echocardiogr. 2011;24:157–69.
AaronsonKD, PatelH, PaganiFD. Patient selection for left ventricular assist device therapy. Ann Thorac Surg. 2003;75(6 suppl):S29–35.
MorganJA, BrewerRJ, NemehHW, MurthyR, WilliamsCT, LanfearDE, TitaC, PaoneG. Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation. ASAIO J. 2012;58:574–7.
TaghaviS, HamadE, WilsonL, ClarkR, JayarajanSN, UrielN, GoldsteinDJ, TakayamaH, NakaY, MangiAA. Mitral valve repair at the time of continuous-flow left ventricular assist device implantation confers meaningful decrement in pulmonary vascular resistance. ASAIO J. 2013;59:469–73.
GregorySD, StevensMC, WuEL, PaulsJP, KleinheyerM, FraserJF. Mitral valve regurgitation with a rotary left ventricular assist device: the haemodynamic effect of inlet cannulation site and speed modulation. Ann Biomed Eng. 2016;44:2674–82.
JelencM, JelencB, VrtovecB, KnezevicI. Mitral regurgitation and axial flow left ventricular assist device: a computer simulation study. ASAIO J. 2013;59:405–9.
PalJD, KlodellCT, JohnR, PaganiFD, RogersJG, FarrarDJ, MilanoCA. HeartMate II Clinical Investigators. Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures. Circulation. 2009;120(11 Suppl):S215–9.
KassisH, CherukuriK, AgarwalR, KanwarM, ElapavaluruS, SokosGG,MoracaRJ, BaileySH, MuraliS, BenzaRL, RainaA. Significance of residual mitral regurgitation after continuous flow left ventricular assist device implantation. J Am Coll Cardiol HF. 2017;5:81–8.
TanakaA, OnsagerD, SongT, CozaddD, KimG, SarswatN, AdatyaS, SayerG, UrielN, JeevanandamV, OtaT. Surgically corrected mitral regurgitation during left ventricular assist device implantation is associated with low recurrence rate and improved midterm survival. Ann Thorac Surg. 2017;103:725–33.
ErtugayS, KemalHS, KahramanU, EnginC, NalbantgilS, YagdiT, OzbaranM. Impact of residual mitral regurgitation on right ventricular systolic function after left ventricular assist device implantation. Artif Organs. 2017;41:622–7.
GoodwinM, NemehHW, BorgiJ, PaoneG, MorganJA. Resolution of mitral regurgitation with left ventricular assist device support. Ann Thorac Surg. 2017;104:811–8.
MaltaisS, AnwerLA. The impact of mitral regurgitation in patients with left ventricular assist devices. J Am Coll Cardiol HF. 2017;5:89–91.
FeldmanD, PamboukianSV, TeutebergJJ, BirksE, LietzK, MooreSA, MorganJA, ArabiaF, BaumanME, BuchholzHW, DengM, DicksteinML, El-BanayosyA, ElliotT, GoldsteinDJ, GradyKL, JonesK, HryniewiczK, JohnR, KaanA, KusneS, LoebeM, MassicotteMP, MoazamiN, MohacsiP, MooneyM, NelsonT, PaganiF, PerryW, PotapovEV, Eduardo RameJ, RussellSD, SorensenEN, SunB, StrueberM, MangiAA, PettyMG, RogersJ. International Society for Heart and Lung Transplantation. The 2013 international society for heart and lung transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32:157–87.
LevineRA, HagégeAA, JudgeDP, PadalaM, Dal-BiancoJP, AikawaE, BeaudoinJ, BischoffJ, Bouatia-NajiN, BrunevalP, ButcherJT, CarpentierA, ChaputM, ChesterAH, CluselC, DellingFN, DietzHC, DinaC, DurstR, Fernandez-FrieraL, HandschumacherMD, JensenMO, JeunemaitreXP, LeMarecH, LeTourneauT, MarkwaldRR, MérotJ, MessasE, MilanDP, NeriT, NorrisRA, PealD, PerrocheauM, ProbstV, PucéatM, RosenthalN, SolisJ, SchottJJ, SchwammenthalE, SlaugenhauptSA, SongJK, YacoubMH. Leducq Mitral Transatlantic Network. Mitral valve disease—morphology and mechanisms. Nat Rev Cardiol. 2015;12:689–710.
KainumaS, TaniguchiK, TodaK, FunatsuT, KondohH, MiyagawaS, YoshikawaY, HataH, SaitoS, UenoT, KurataniT, DaimonT, MasaiT, SawaY. Osaka Cardiovascular Surgery Research (OSCAR) Group. Predictors and clinical impact of functional mitral stenosis induced by restrictive annuloplasty for ischemic and functional mitral regurgitation. Circ J. https://doi.org/10.1253/circj.CJ-17-0060. 2017.
Acknowledgements
This work was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI; Grant Number JP16K10446).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Hata, H., Fujita, T., Ishibashi-Ueda, H. et al. Impact of mitral valve intervention with left ventricular assist device implantation on postoperative outcomes and morphologic change. J Artif Organs 21, 164–171 (2018). https://doi.org/10.1007/s10047-017-1010-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-017-1010-5